Serial Number | 98921341 |
Word Mark | LCB |
Filing Date | Tuesday, December 24, 2024 |
Status | 680 - APPROVED FOR PUBLICATION |
Status Date | Thursday, September 18, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of the stylized letters "LCB" in the color brown. |
Pseudo Mark | LIGACHEM BIOSCIENCES |
Indication of Colors claimed | The color(s) brown is/are claimed as a feature of the mark. |
Goods and Services | Research and development of vaccines and medicines; biomedical research services; biological research and analysis; research of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; Research and development in the field of pharmaceuticals and biotechnology; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; research on the subject of pharmaceuticals; drug development, namely, pharmaceutical drug development services in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; medical and pharmaceutical research services; research in the field of medical preparations; medical research laboratory services; medicine research, namely, medical research services relating to medicines in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; providing PAAS (platform as a service) featuring computer software used to conduct research and development in the field of pharmaceuticals, biotechnology and drugs; laboratory research services relating to pharmaceuticals; Technology research in the field of medical instruments; testing of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical research and analysis |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, December 24, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | LigaChem Biosciences Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Yuseong-gu, Daejeon 34002 KR |
Event Date | Event Description |
Tuesday, December 24, 2024 | NEW APPLICATION ENTERED |
Tuesday, June 3, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, July 9, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, September 16, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, September 16, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, September 18, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, September 16, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, June 10, 2025 | ASSIGNED TO EXAMINER |
Wednesday, July 9, 2025 | NON-FINAL ACTION WRITTEN |
Wednesday, July 9, 2025 | NON-FINAL ACTION E-MAILED |